Half-year report · Q2
7776.TEDINET S100WJ5L
Period2025-01-01 → 2025-06-30
Filed2025-08-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥37m | 2025-01-01 → 2025-06-30 | Standalone | Net sales |
| Revenue | ¥193m | 2024-01-01 → 2024-12-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥76m | 2024-01-01 → 2024-06-30 | Standalone | Net sales |
| Operating income | −¥623m | 2025-01-01 → 2025-06-30 | Standalone | Operating income |
| Operating income | −¥464m | 2024-01-01 → 2024-06-30 | Standalone | Operating income |
| Ordinary income | −¥624m | 2025-01-01 → 2025-06-30 | Standalone | Ordinary income |
| Ordinary income | −¥848m | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥463m | 2024-01-01 → 2024-06-30 | Standalone | Ordinary income |
| Profit before tax | −¥651m | 2025-01-01 → 2025-06-30 | Standalone | Income before income taxes |
| Profit before tax | −¥473m | 2024-01-01 → 2024-06-30 | Standalone | Income before income taxes |
| Net income | −¥651m | 2025-01-01 → 2025-06-30 | Standalone | Profit loss |
| Net income | −¥860m | 2024-01-01 → 2024-12-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥474m | 2024-01-01 → 2024-06-30 | Standalone | Profit loss |
| Total assets | ¥1.9bn | at 2025-06-30 | Standalone | Assets |
| Total assets | ¥2.4bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥2.4bn | at 2024-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥400m | at 2025-06-30 | Standalone | Liabilities |
| Total liabilities | ¥270m | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.5bn | at 2025-06-30 | Standalone | Net assets |
| Net assets / equity | ¥2.2bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥2.1bn | at 2024-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.7bn | at 2025-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.1bn | at 2024-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.7bn | at 2025-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2024-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2024-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2023-12-31v | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥473m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥866m | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥405m | 2024-01-01 → 2024-06-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥717,000 | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥18m | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6m | 2024-01-01 → 2024-06-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | −¥4m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥855m | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥422m | 2024-01-01 → 2024-06-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-18.78 | 2025-01-01 → 2025-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-25.72 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.74 | 2024-01-01 → 2024-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 78.5% | at 2025-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.5% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.4% | at 2024-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 34,666,419 | at 2025-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 34,666,419 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 33,447,119 | at 2024-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥115m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥2m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥2m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥449m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥35m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥35m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥59m |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥37m |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥37m |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | −¥508m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥113m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥1m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥1m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥332m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥75m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥75m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥19m |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥76m |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥76m |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | −¥351m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 429
| Item | Context | Value | Unit |
|---|---|---|---|
| Accounts receivable trade | CurrentQuarterInstant_NonConsolidatedMember | 1775000 | JPY |
| Merchandise and finished goods | Prior1YearInstant_NonConsolidatedMember | 12476000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant_NonConsolidatedMember | 17843000 | JPY |
| Work in process | Prior1YearInstant_NonConsolidatedMember | 9448000 | JPY |
| Work in process | CurrentQuarterInstant_NonConsolidatedMember | 4895000 | JPY |
| Raw materials and supplies | Prior1YearInstant_NonConsolidatedMember | 24065000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant_NonConsolidatedMember | 24919000 | JPY |
| Other ca | Prior1YearInstant_NonConsolidatedMember | 94802000 | JPY |
| Other ca | CurrentQuarterInstant_NonConsolidatedMember | 72270000 | JPY |
| Current assets | Prior1YearInstant_NonConsolidatedMember | 2312219000 | JPY |
| Current assets | CurrentQuarterInstant_NonConsolidatedMember | 1777868000 | JPY |
| Investments and other assets | Prior1YearInstant_NonConsolidatedMember | 120865000 | JPY |
| Investments and other assets | CurrentQuarterInstant_NonConsolidatedMember | 135121000 | JPY |
| Noncurrent assets | Prior1YearInstant_NonConsolidatedMember | 120865000 | JPY |
| Noncurrent assets | CurrentQuarterInstant_NonConsolidatedMember | 135121000 | JPY |
| Assets | Prior1YearInstant_NonConsolidatedMember | 2433084000 | JPY |
| Assets | CurrentQuarterInstant_NonConsolidatedMember | 1912989000 | JPY |
| Accounts payable trade | Prior1YearInstant_NonConsolidatedMember | 6183000 | JPY |
| Accounts payable trade | CurrentQuarterInstant_NonConsolidatedMember | 210000 | JPY |
| Accounts payable other | Prior1YearInstant_NonConsolidatedMember | 43687000 | JPY |
| Accounts payable other | CurrentQuarterInstant_NonConsolidatedMember | 202709000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant_NonConsolidatedMember | 10834000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant_NonConsolidatedMember | 22503000 | JPY |
| Provision for bonuses | Prior1YearInstant_NonConsolidatedMember | 4228000 | JPY |
| Provision for bonuses | CurrentQuarterInstant_NonConsolidatedMember | 3974000 | JPY |
| Other cl | Prior1YearInstant_NonConsolidatedMember | 38212000 | JPY |
| Other cl | CurrentQuarterInstant_NonConsolidatedMember | 20006000 | JPY |
| Current liabilities | Prior1YearInstant_NonConsolidatedMember | 103144000 | JPY |
| Current liabilities | CurrentQuarterInstant_NonConsolidatedMember | 249403000 | JPY |
| Long term loans payable | Prior1YearInstant_NonConsolidatedMember | 132916000 | JPY |
| Long term loans payable | CurrentQuarterInstant_NonConsolidatedMember | 116872000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant_NonConsolidatedMember | 33819000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant_NonConsolidatedMember | 33865000 | JPY |
| Noncurrent liabilities | Prior1YearInstant_NonConsolidatedMember | 166735000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant_NonConsolidatedMember | 150737000 | JPY |
| Liabilities | Prior1YearInstant_NonConsolidatedMember | 269880000 | JPY |
| Liabilities | CurrentQuarterInstant_NonConsolidatedMember | 400141000 | JPY |
| Capital stock | Prior1YearInstant_NonConsolidatedMember | 2819386000 | JPY |
| Capital stock | CurrentQuarterInstant_NonConsolidatedMember | 2152299000 | JPY |
| Capital surplus | Prior1YearInstant_NonConsolidatedMember | 1798967000 | JPY |
| Capital surplus | CurrentQuarterInstant_NonConsolidatedMember | - | JPY |
| Retained earnings | Prior1YearInstant_NonConsolidatedMember | -2466054000 | JPY |
| Retained earnings | CurrentQuarterInstant_NonConsolidatedMember | -651162000 | JPY |
| Treasury stock | Prior1YearInstant_NonConsolidatedMember | -227000 | JPY |
| Treasury stock | CurrentQuarterInstant_NonConsolidatedMember | -227000 | JPY |
| Shareholders equity | Prior1YearInstant_NonConsolidatedMember | 2152071000 | JPY |
| Shareholders equity | CurrentQuarterInstant_NonConsolidatedMember | 1500909000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant_NonConsolidatedMember | 747000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant_NonConsolidatedMember | 1554000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant_NonConsolidatedMember | 747000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |